Followers | 612 |
Posts | 26807 |
Boards Moderated | 0 |
Alias Born | 08/12/2010 |
Wednesday, November 29, 2017 9:41:24 AM
Look at the other possible neurological disorders this may serve!!
FDA TRIALS PHASE II Soon!!!
http://www.receptopharm.com/drug_development/
RPI-78M is being developed for the treatment of Multiple Sclerosis (MS) and Adrenomyeloneuropathy (AMN). Other neurological disorders that may be served by RPI-78M include Myasthenia Gravis (MG) and Amyotrophic Lateral Sclerosis (ALS).
RPI-MN and RPI-78M possess several desirable properties as drugs:
They lack measurable toxicity but are still capable of attaching to and affecting the target site on the nerve cells. This means that patients cannot overdose.
They display no serious adverse side effects following years of investigations in humans and animals.
They are extremely stable and resistant to heat, which gives the drugs a long shelf life. The drugs' stability has been determined to be over 4 years at room temperature. This is extremely unusual for a biologic drug.
They are easy to administer.
RPI-78M can be administered orally a first for a biologic MS drug. This will present MS patients with additional quality of life benefits by eliminating the requirement for routine injections.
RPI-78M
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration
https://finance.yahoo.com/news/nutra-pharmas-rpi-78m-granted-123000069.html
RPI-78M
Collaboration: University of Maryland,production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple Sclerosis
https://finance.yahoo.com/news/nutra-pharma-announces-collaboration-university-123000318.html
Interesting Older Post on Market Cap Related to the Orphan Drug Status and FDA Trials......
I believe with the toxic's everything had been slowed down to a crawl. I also believe things are soon to pick up steam.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133351752
30 million Market Cap: PPS .015
100 million Market Cap: PPS .05
Those numbers were based primarily on the Orphan Drug Status - Pediatric MS going to Phase II FDA trials!
ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM